查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1641762

全球热疗设备市场（按产品、应用和最终用户划分）- 机会分析和产业预测，2024 年至 2033 年

Hyperthermia Devices Market By Product , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 290 Pages | 商品交期: 2-3个工作天内

价格
简介目录

高温治疗设备市场规模预计在 2023 年将达到 1.682 亿美元，到 2033 年将达到 2.901 亿美元，2024 年至 2033 年的复合年增长率为 5.6%。

高温治疗设备市场-IMG1

高温机是医疗设备，通常作为癌症的辅助治疗。透过对身体特定部位进行控制加热，可以改善血液流动并使癌细胞更容易接受治疗，从而增强化疗和放射线治疗等治疗效果。

全球热疗市场的成长是由全球癌症患者数量的增加所推动的，这推动了对创新治疗方法，包括热疗设备，以提高化疗和放射线治疗等传统癌症治疗的有效性。根据世界卫生组织 (WHO) 2022 年发布的一项研究，癌症是全球主要死亡原因，2020 年导致约 1000 万人死亡。因此，随着越来越多的患者寻求微创的癌症治疗方法，热疗设备因其能够针对局部组织同时与传统方法相比最大限度地减少副作用而越来越受欢迎。此外，人们越来越认识到热疗的益处，包括其在改善治疗结果和减少副作用方面的作用，导致其在临床实践中的接受度越来越高。此外，人们越来越意识到热疗的益处，包括其在改善治疗结果和减少副作用方面的作用，这使得其在临床环境中得到更广泛的接受，从而推动了市场的成长。此外，老年人口的快速增加是全球市场的主要动力。这是因为老龄化与免疫系统效率降低有关，包括控制异常和癌细胞的能力下降。这对包括热疗设备在内的先进治疗方案产生了巨大的需求。世界卫生组织（WHO）2024年发布的一项研究显示，老年人口数量将从2020年的10亿增加到2030年的14亿。此外，到2050年，80岁及以上人口数量预计将达到4.26亿人。全球专科肿瘤诊所和医院数量的不断增长，进一步推动了热疗等先进癌症治疗方法的采用，以改善患者的治疗效果。儘管热疗有许多好处，但由于医疗保健提供者对其功效及其与癌症治疗方案的结合程度的认识和培训有限，热疗仍未得到充分利用。高温治疗的成本（包括设备和相关程序）对于许多患者和医疗保健系统来说是难以承受的，特别是在中低收入地区，这进一步抑制了市场的成长。相反，改进的热传输系统、即时温度监测和非侵入式设备等技术创新正在使热疗治疗更加安全、准确和有效。预计这些发展将为预测期内全球市场的扩张提供有利可图的机会。

全球热疗设备市场分析分为产品、应用、最终用户和地区。根据产品，市场分为微波热疗设备和超音波热疗设备。依用途分为乳癌、摄护腺癌、子宫颈癌等。根据最终用户，市场分为医院、癌症治疗中心和其他。根据地区，分析范围涵盖北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。

主要发现

根据产品，超音波热疗设备领域预计将在 2024 年至 2033 年期间占据市场主导地位。

根据应用，预计前列腺癌部分将在整个预测期内呈现最高增长。

根据最终用户，医院部门预计在预测期内将大幅成长。

根据地区，预计北美将在 2023 年占据最大的市场占有率（以收益为准） ，并且很可能在预测期内继续占据市场主导地位。

全球高温设备市场的主要企业包括 Pyrexar Medical、Oncotherm、Celsius42、Andromedic、Pearson、南京 Greathope、上海华远、MagForce AG、Nanopores 和 Sensius。这些主要企业正在采取业务扩张、新产品推出和联盟等各种关键发展策略，以在竞争激烈的市场中站稳脚跟。

此报告可进行客製化（可能需要支付额外费用和製定时间表）

  • 国家、地区和全球层面的患者/流行病学资料
  • 监管指南
  • 根据客户兴趣提供额外的公司简介
  • 按国家或地区进行的额外分析 - 市场规模和预测
  • 扩展公司简介列表
  • 历史市场资料
  • SWOT 分析

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 重大投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会

第四章 热疗设备市场（依产品）

  • 市场概况
  • 微波热疗装置
  • 超音波热疗仪

第五章 热疗设备市场依应用

  • 市场概况
  • 乳癌
  • 摄护腺癌
  • 子宫颈癌
  • 其他的

第六章 热疗设备市场（依最终用户）

  • 市场概况
  • 医院
  • 癌症治疗中心
  • 其他的

第七章 热疗设备市场（按地区）

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国高温设备市场
    • 加拿大高温设备市场
    • 墨西哥的高温治疗设备市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国热疗设备市场
    • 德国热疗设备市场
    • 义大利热疗设备市场
    • 西班牙高温设备市场
    • 英国热疗设备市场
    • 其他欧洲国家热疗设备市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国热疗设备市场
    • 日本热疗设备市场
    • 印度热疗设备市场
    • 韩国热疗设备市场
    • 澳洲热疗设备市场
    • 其他亚太地区热疗设备市场
  • 拉丁美洲、中东和非洲
    • 主要市场趋势和机会
    • 巴西热疗设备市场
    • 南非热疗设备市场
    • 沙乌地阿拉伯的高温治疗设备市场
    • 其他拉丁美洲、中东和非洲热疗设备市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 2023年主要企业的定位

第九章 公司简介

  • Pyrexar Medical
  • Oncotherm
  • Celsius42
  • Andromedic
  • Pearson
  • Nanjing Greathope
  • Shanghai Huayuan
  • MagForce AG
  • Nanopores
  • Sensius
简介目录
Product Code: A324444

The hyperthermia devices market was valued at $168.2 million in 2023, and is projected to reach $290.1 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Hyperthermia Devices Market - IMG1

Hyperthermia devices are medical instruments used to raise the temperature of body tissues for therapeutic purposes, often as an adjunct treatment for cancer. By applying controlled heat to specific areas of the body, these devices enhance the efficacy of treatments like chemotherapy and radiation therapy by improving blood flow and increasing the sensitivity of cancer cells to treatment.

The growth of the global hyperthermia devices market is driven by global increase in cancer cases has driven demand for innovative treatment modalities, including hyperthermia devices, which improve the efficacy of traditional cancer therapies like chemotherapy and radiation. According to a 2022 study published by the World Health Organization, cancer is a leading cause of death worldwide, which accounted for nearly 10 million deaths in 2020. Thus, with patients increasingly seeking less invasive cancer treatments, hyperthermia devices have gained popularity due to their ability to target localized tissues with minimal side effects compared to conventional approaches. In addition, increase in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice. Moreover, rise in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice, thus fostering the market growth. Furthermore, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that aging is associated with a decline in immune system efficiency, including reduced surveillance for abnormal or cancerous cells. This has created a significant demand for advanced therapeutic options, including hyperthermia devices. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. The growth of specialized oncology clinics and hospitals worldwide has further facilitated the adoption of advanced cancer treatment modalities, such as hyperthermia therapy, to improve patient outcomes. Despite its benefits, hyperthermia therapy remains underutilized due to limited awareness and training among healthcare providers about its effectiveness and integration into cancer treatment protocols. The cost of hyperthermia treatment, including the devices and associated procedures, can be prohibitive for many patients and healthcare systems, particularly in low- and middle-income regions, further restraining the market growth. On the contrary, Technological innovations, such as improved thermal delivery systems, real-time temperature monitoring, and non-invasive devices, have enhanced the safety, precision, and effectiveness of hyperthermia treatments. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global hyperthermia devices market analysis is segmented into product, application, end user, and region. On the basis of product, the market is categorized into microwave hyperthermia devices and ultrasound hyperthermia devices. Depending on application, it is segregated into breast cancer, prostate cancer, cervical cancer, and others. By end user, it is fragmented into hospitals, cancer treatment centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the ultrasound hyperthermia devices segment is expected to dominate the market from 2024 to 2033.

Depending on application, the prostate cancer segment is anticipated to exhibit the highest growth throughout the forecast period.

By end user, the hospitals segment is projected to grow at a notable pace during the forecast period.

Region wise, North America held the largest market share, in terms of revenue, in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

The major players operating in the global hyperthermia devices Market include Pyrexar Medical, Oncotherm, Celsius42, Andromedic, Pearson, Nanjing Greathope, Shanghai Huayuan, MagForce AG, Nanopores, and Sensius. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product

  • Microwave Hyperthermia Devices
  • Ultrasound Hyperthermia Devices

By Application

  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Others

By End User

  • Hospitals
  • Cancer treatment centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Pyrexar Medical
    • Oncotherm
    • Celsius42
    • Andromedic
    • Pearson
    • Nanjing Greathope
    • Shanghai Huayuan
    • MagForce AG
    • Nanopores
    • Sensius

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: HYPERTHERMIA DEVICES MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Microwave Hyperthermia Devices
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Ultrasound Hyperthermia Devices
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: HYPERTHERMIA DEVICES MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Breast Cancer
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Prostate Cancer
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Cervical Cancer
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: HYPERTHERMIA DEVICES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Cancer Treatment Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: HYPERTHERMIA DEVICES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Hyperthermia Devices Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Hyperthermia Devices Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Hyperthermia Devices Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Hyperthermia Devices Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Hyperthermia Devices Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Hyperthermia Devices Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Hyperthermia Devices Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Hyperthermia Devices Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Hyperthermia Devices Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Hyperthermia Devices Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Hyperthermia Devices Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Hyperthermia Devices Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Hyperthermia Devices Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Hyperthermia Devices Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Hyperthermia Devices Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Hyperthermia Devices Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Hyperthermia Devices Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Hyperthermia Devices Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Hyperthermia Devices Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Pyrexar Medical
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Oncotherm
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Celsius42
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Andromedic
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Pearson
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Nanjing Greathope
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Shanghai Huayuan
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MagForce AG
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Nanopores
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Sensius
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments